Literature DB >> 15324341

The assessment of patients with long-term psychotic disorders: application of the WHO Disability Assessment Schedule II.

P K Chopra1, J W Couper, H Herrman.   

Abstract

OBJECTIVES: To evaluate the use of the World Health Organization Disability Assessment Schedule II (WHODAS II), a patient questionnaire measuring disability, in patients treated for long-term psychotic disorders.
METHOD: The study was conducted at St. Vincent's Mental Health Service, Melbourne, Australia. Twenty patients with long-term psychotic disorders under the care of either the residential Community Care Unit or the outpatient Mobile Support and Treatment Service were selected. For all 20 patients a clinician assessment of disability and functional status was recorded using the International Classification of Impairments, Disabilities and Handicaps-2 (ICIDH-2), Life Skills Profile (LSP) and Health of the Nation Outcome Scale (HoNOS). The WHODAS II survey was then administered to each patient. The WHODAS II was re-administered by a second rater within 5 days of the initial assessment for the purpose of test-retest reliability analysis. Each patient also completed the WHO Quality of Life instrument (brief version) (WHQOL-BREF), a self-report questionnaire on quality of life.
RESULTS: The WHODAS II was experienced as relatively complex and at times difficult to administer with full co-operation in this clinical context. Overall, test-retest reliability was fair. The information it yielded gave valuable insights into patients' experiences. Most of the participants reported fewer impairments in mental functions and fewer activity limitations than reported by clinicians. However, patients reported significant restrictions in participation in social activities and limitations due to environmental barriers. The WHOQOL-BREF highlighted difficulties experienced by patients in their participation in society, through exploring difficulties and satisfaction with various aspects of life experience and this instrument was well accepted.
CONCLUSIONS: The self-reported experience of patients is needed alongside clinician-rated measures to assess outcomes in people with long-term psychotic disorders. The WHODAS II records and measures patients' own experiences of disability. It may be used together with the WHOQOL-BREF, a distinct and complementary self-report assessment of quality of life.

Entities:  

Mesh:

Year:  2004        PMID: 15324341     DOI: 10.1080/j.1440-1614.2004.01448.x

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  27 in total

1.  Developing the World Health Organization Disability Assessment Schedule 2.0.

Authors:  T Bedirhan Ustün; Somnath Chatterji; Nenad Kostanjsek; Jürgen Rehm; Cille Kennedy; Joanne Epping-Jordan; Shekhar Saxena; Michael von Korff; Charles Pull
Journal:  Bull World Health Organ       Date:  2010-05-20       Impact factor: 9.408

2.  Retention in depression treatment among ethnic and racial minority groups in the United States.

Authors:  Lisa R Fortuna; Margarita Alegria; Shan Gao
Journal:  Depress Anxiety       Date:  2010-05       Impact factor: 6.505

Review 3.  Clinical Predictors of Response to Clozapine in Patients with Treatment Resistant Schizophrenia.

Authors:  Rajkumar A P; Chitra C; Bhuvaneshwari S; Poonkuzhali B; Kuruvilla A; Jacob K S
Journal:  Psychopharmacol Bull       Date:  2011-09-15

4.  The relationship between health, disability and quality of life in myasthenia gravis: results from an Italian study.

Authors:  Matilde Leonardi; Alberto Raggi; Carlo Antozzi; Paolo Confalonieri; Lorenzo Maggi; Ferdinando Cornelio; Renato Mantegazza
Journal:  J Neurol       Date:  2009-08-08       Impact factor: 4.849

5.  Psychometric properties of the WHODASII in rehabilitation patients.

Authors:  Miriam Pösl; Alarcos Cieza; Gerold Stucki
Journal:  Qual Life Res       Date:  2007-09-09       Impact factor: 4.147

6.  Validation of the "World Health Organization Disability Assessment Schedule, WHODAS-2" in patients with chronic diseases.

Authors:  Olatz Garin; Jose Luis Ayuso-Mateos; Josué Almansa; Marta Nieto; Somnath Chatterji; Gemma Vilagut; Jordi Alonso; Alarcos Cieza; Olga Svetskova; Helena Burger; Vittorio Racca; Carlo Francescutti; Eduard Vieta; Nenad Kostanjsek; Alberto Raggi; Matilde Leonardi; Montse Ferrer
Journal:  Health Qual Life Outcomes       Date:  2010-05-19       Impact factor: 3.186

7.  Psychometric properties of the World Health Organization Disability Assessment Schedule used in the European Study of the Epidemiology of Mental Disorders.

Authors:  M A Buist-Bouwman; J Ormel; R De Graaf; G Vilagut; J Alonso; E Van Sonderen; W A M Vollebergh
Journal:  Int J Methods Psychiatr Res       Date:  2008       Impact factor: 4.035

8.  Modified WHODAS-II provides valid measure of global disability but filter items increased skewness.

Authors:  Michael Von Korff; Paul K Crane; Jordi Alonso; Gemma Vilagut; Matthias C Angermeyer; Ronny Bruffaerts; Giovanni de Girolamo; Oye Gureje; Ron de Graaf; Yueqin Huang; Noboru Iwata; Elie G Karam; Viviane Kovess; Carmen Lara; Daphna Levinson; José Posada-Villa; Kate M Scott; Johan Ormel
Journal:  J Clin Epidemiol       Date:  2008-07-10       Impact factor: 6.437

9.  Contribution of chronic diseases to disability in elderly people in countries with low and middle incomes: a 10/66 Dementia Research Group population-based survey.

Authors:  Renata M Sousa; Cleusa P Ferri; Daisy Acosta; Emiliano Albanese; Mariella Guerra; Yueqin Huang; K S Jacob; A T Jotheeswaran; Juan J Llibre Rodriguez; Guillermina Rodriguez Pichardo; Marina Calvo Rodriguez; Aquiles Salas; Ana Luisa Sosa; Joseph Williams; Tirso Zuniga; Martin Prince
Journal:  Lancet       Date:  2009-11-28       Impact factor: 79.321

10.  Measuring disability across cultures--the psychometric properties of the WHODAS II in older people from seven low- and middle-income countries. The 10/66 Dementia Research Group population-based survey.

Authors:  Renata M Sousa; Michael E Dewey; Daisy Acosta; A T Jotheeswaran; Erico Castro-Costa; Cleusa P Ferri; Mariella Guerra; Yueqin Huang; K S Jacob; Juana Guillermina Rodriguez Pichardo; Nayeli Garcia Ramírez; Juan Llibre Rodriguez; Marina Calvo Rodriguez; Aquiles Salas; Ana Luisa Sosa; Joseph Williams; Martin J Prince
Journal:  Int J Methods Psychiatr Res       Date:  2010-03       Impact factor: 4.035

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.